Abstract
Purpose of ReviewObstructive Sleep Apnea (OSA) is a common sleep disorder with significant cardiovascular implications, affecting a broad adult demographic. This review explores OSA’s link to cardiovascular diseases and assesses Continuous Positive Airway Pressure (CPAP) therapy’s role in managing these conditions.Recent FindingsOSA is associated with coronary heart disease, heart failure, hypertension, arrhythmias, and pulmonary hypertension, due to intermittent hypoxia, inflammation, and sympathetic activation. CPAP therapy, known for enhancing sleep and reducing daytime fatigue, has varying impacts on cardiovascular health.SummaryWhile results on coronary heart disease are mixed, CPAP shows promise in improving heart failure outcomes, reducing hypertension, and managing arrhythmias, with potential benefits for pulmonary hypertension through improved hemodynamics. This underscores CPAP’s value in OSA’s holistic management, highlighting its beyond-respiratory benefits. However, adherence challenges persist, calling for more research on CPAP’s long-term cardiovascular effects. This advocates a multidisciplinary approach to OSA, considering its extensive health consequences.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
